David J. Maloney
Founder at Veralox Therapeutics, Inc.
Profile
David J.
Maloney is the founder of Veralox Therapeutics, Inc. (founded in 2017) where he holds the title of Chief Scientific Officer.
In 2017, he worked as Vice President & Head-Translational Medicine at Rebus Holdings, Inc. Dr. Maloney holds a doctorate from the University of Virginia and an undergraduate degree from the University of Vermont.
David J. Maloney active positions
| Companies | Position | Start |
|---|---|---|
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Founder | 2016-12-31 |
Former positions of David J. Maloney
| Companies | Position | End |
|---|---|---|
| REBUS HOLDINGS, INC. | Corporate Officer/Principal | 2017-11-30 |
Training of David J. Maloney
| University of Virginia | Doctorate Degree |
| University of Vermont | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| REBUS HOLDINGS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Health Technology |
- Stock Market
- Insiders
- David J. Maloney
